Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(18 sites)
United States
Research Site 10, Jacksonville, Florida Research Site 17, Orlando, Florida Research Site 11, Port Orange, Florida Research Site 14, Durham, North Carolina Research Site 13, High Point, North Carolina Research Site 9, Cleveland, Ohio Research Site 12, Portland, Oregon Australia
Research Site 1, Adelaide Research Site 15, Brisbane Research Site 16, Brisbane Research Site 7, Camperdown Research Site 3, Heidelberg Research Site 2, Melbourne New Zealand
Research Site 5, Auckland Research Site 4, Christchurch United Kingdom
Research Site 18, Cambridge